Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
A vast amount of studies suggest that immunotherapy may represent an effective new treatment approach for malignant mesothelioma. Learn your options here.